The case of an infant thought to have an extremely rare form of prophyria, called harderoporphyria, was described in a recent report.| Porphyria News
Givlaari (givosiran) is an RNA-interference therapy by Alnylam Pharmaceuticals to treat adults with acute hepatic porphyria.| Porphyria News
A real-world study analyzed the medical records of EPP and XLP patients in the U.S. who waited about three years for a porphyria diagnosis.| Porphyria News
Acute hepatic porphyria carriers may show subtle disease signs in the absence of acute attacks, and should be watched, per a study.| Porphyria News
Marisa Wexler is a senior science writer for Porphyria News with an MS in cellular and molecular pathology. She covers the latest news and information on a variety of porphyria topics.| Porphyria News
For columnist Kalyn Shelton, symptoms of porphyria can include anxiety, depression, mood swings, and hallucinations.| Porphyria News
Category archive page for News.| Porphyria News